AR081220A1 - USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY - Google Patents
USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHYInfo
- Publication number
- AR081220A1 AR081220A1 ARP110101770A ARP110101770A AR081220A1 AR 081220 A1 AR081220 A1 AR 081220A1 AR P110101770 A ARP110101770 A AR P110101770A AR P110101770 A ARP110101770 A AR P110101770A AR 081220 A1 AR081220 A1 AR 081220A1
- Authority
- AR
- Argentina
- Prior art keywords
- teriflunomide
- treatment
- brain atrophy
- atrophy
- brain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Uso de teriflunomida para tratar la atrofia cerebral en un paciente que lo necesita.Use of teriflunomide to treat cerebral atrophy in a patient in need.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34849410P | 2010-05-26 | 2010-05-26 | |
US38937510P | 2010-10-04 | 2010-10-04 | |
US39140010P | 2010-10-08 | 2010-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR081220A1 true AR081220A1 (en) | 2012-07-04 |
Family
ID=44211940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110101770A AR081220A1 (en) | 2010-05-26 | 2011-05-24 | USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR081220A1 (en) |
TW (1) | TW201208674A (en) |
UY (1) | UY33411A (en) |
WO (1) | WO2011150014A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012061062A1 (en) * | 2010-10-25 | 2012-05-10 | Sanofi-Aventis U.S. Llc | Use of teriflunomide for improving motor function |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268382A (en) | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
-
2011
- 2011-05-24 AR ARP110101770A patent/AR081220A1/en unknown
- 2011-05-25 TW TW100118220A patent/TW201208674A/en unknown
- 2011-05-25 WO PCT/US2011/037847 patent/WO2011150014A1/en active Application Filing
- 2011-05-26 UY UY0001033411A patent/UY33411A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW201208674A (en) | 2012-03-01 |
WO2011150014A1 (en) | 2011-12-01 |
UY33411A (en) | 2011-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP24031979A (en) | THERAPEUTIC ACTIVE COMPOUNDS AND THEIR METHODS OF USE | |
ECSP14017269A (en) | COMPOUNDS TO TREAT SPINAL MUSCULAR ATROPHY | |
CU20120161A7 (en) | 5-FLUORO-1H-SUBSTITUTED PIRAZOLOPIRIDINS | |
CA2900335C (en) | Synthetic analogs of epipolythiodioxopiperazines and uses thereof | |
AR089993A1 (en) | PEPTIDOMIMETIC MACROCICLES | |
PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
UY34165A (en) | ? ALDH-2 HUMAN MITOCONDRIAL COMPOUNDS FOR ADDICTION TREATMENT ?. | |
CL2012003385A1 (en) | Incontinence treatment. | |
BRPI1013698A2 (en) | methods for treatment with the use of combination therapy | |
IL229474A0 (en) | Cannabinoids for use in the treatment of neuropatich pain | |
CR20130464A (en) | ACETIL-COA CARBOXILASA REPLACED INHIBITORS | |
BR112014013843A2 (en) | use of devices for the treatment of neurological diseases | |
MX356728B (en) | Pharmaceutical combination for use in the treatment of diabetes type 2. | |
BR112012029746A2 (en) | skin treatment composition, method for providing a microbicidal effect to the skin and use of a combination | |
CO7160080A2 (en) | Lipid compositions of racecadot | |
BR112015027477A8 (en) | bolus, its uses, and kit | |
BR112014000634A2 (en) | Methods for treating incontinence associated with sexual activity | |
GT201400242A (en) | "NEW COMPOUNDS OF PIRAZOL" | |
FI20115165A0 (en) | Therapeutic and diagnostic methods | |
CO7121334A2 (en) | Vesicular formulations | |
BR112014000670A2 (en) | use of oligosaccharide compounds for the prevention and treatment of pathological scars | |
ECSP17021138A (en) | DIPEPTIDIL-KETOAMIDE COMPOUNDS AND THEIR USE FOR THE TREATMENT AND / OR PREVENTION OF FAT ACCUMULATION | |
AR081220A1 (en) | USE OF TERIFLUNOMIDE FOR THE TREATMENT OF BRAIN ATROPHY | |
AR082436A1 (en) | USE OF TERIFLUNOMIDE TO TREAT MULTIPLE SCLEROSIS | |
IN2014KN01772A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |